The nation's largest not-for-profit hospital systems reaped more than $21 billion last year from their Wall Street investments, mergers and other investment options, according to an Axios analysis of financial documents. More
Every day is Halloween for pharma marketers... More
Researchers and advocates are up in arms over a new review of Hepatitis C treatments. But look who's funding each side... More
From industry payments to kickbacks, corruption is everywhere in health care. And it comes at a high cost to patient safety. More
When researchers and the press started asking about duloxetine, the FDA didn’t scour its database and go public. It kept quiet. More